Thus, while current inhibitors blocking YAP/TAZ-TEAD function might be effective against tumor angiogenesis, a more potent inhibition of tumor angiogenesis may be achieved by blocking complex formation between YAP/TAZ, AP1, and STAT3. The gene discussed is FOS; the disease is neoplasm.